Archive · 5 Aug 2025
R-Pharm Sues Raiffeisenbank Russian Unit for Millions
A Russian pharmaceutical company called R-Pharm is suing Raiffeisenbank, a bank with a Russian branch, for a lot of money - 337.5 million euros!
We don't know exactly why, but a newspaper says it might be because R-Pharm couldn't sell a factory they own in Germany.
The bank was supposed to help find a buyer.
Raiffeisenbank is still operating in Russia, even though some other banks have left.
A court date is set for this lawsuit to begin on August 12th.
R-Pharm International, a Moscow-based biotech firm, sued Raiffeisenbank's Russian unit for 337.5 million euros.
The lawsuit's specific reason isn't stated in court filings.
Vedomosti newspaper reported the suit is due to lost profits from a German production facility.
Raiffeisenbank was hired in June 2023 to find a buyer for R-Pharm's plant in Germany.
A preliminary hearing in the case is scheduled for August 12.
- Who
- R-Pharm International and Raiffeisenbank.
- What
- R-Pharm International sued Raiffeisenbank's Russian unit.
- When
- A preliminary hearing is scheduled for August 12.
- Where
- Moscow, Russia (R-Pharm) and Germany (Production facility).
- Why
- Possibly due to lost profits from a German production facility, as reported by a newspaper.
R-Pharm
Raiffeisenbank
Damages
R-Pharm
R-Pharm is seeking compensation from Raiffeisenbank.
Raiffeisenbank
Raiffeisenbank's stance is not available in the articles.
- Plaintiff
- R-Pharm International
- Defendant
- Raiffeisenbank's Russian unit
- Claim Amount
- 337.5 million euros
- Court Date
- August 12
- Related to
- Loss of profit from a German plant
- Plant Location
- Illertissen, Bavaria, Germany